Multiple pathways regulated by the tumor suppressor PP2A in transformation - PubMed (original) (raw)
Review
Multiple pathways regulated by the tumor suppressor PP2A in transformation
Jukka Westermarck et al. Trends Mol Med. 2008 Apr.
Abstract
Reversible protein phosphorylation plays a central role in regulating intracellular signaling. Dysregulation of the mechanisms that regulate phosphorylation plays a direct role in cancer initiation and maintenance. Although abundant evidence supports the role of kinase oncogenes in cancer development, recent work has illuminated the role of specific protein phosphatases in malignant transformation. Protein phosphatase 2A (PP2A) is the major serine-threonine phosphatase in mammalian cells. Inactivation of PP2A by viral oncoproteins, mutation of specific subunits or overexpression of endogenous inhibitors contributes to cell transformation by regulating specific phosphorylation events. Here, we review recent progress in our understanding of how PP2A regulates mitogenic signaling pathways in cancer pathogenesis and how PP2A activity is modulated in human cancers.
Similar articles
- Involvement of PP2A in viral and cellular transformation.
Arroyo JD, Hahn WC. Arroyo JD, et al. Oncogene. 2005 Nov 21;24(52):7746-55. doi: 10.1038/sj.onc.1209038. Oncogene. 2005. PMID: 16299534 Review. - SV40 small T antigen and PP2A phosphatase in cell transformation.
Sablina AA, Hahn WC. Sablina AA, et al. Cancer Metastasis Rev. 2008 Jun;27(2):137-46. doi: 10.1007/s10555-008-9116-0. Cancer Metastasis Rev. 2008. PMID: 18214640 Review. - [Protein phosphatase 2A: its structure, function and activity regulation].
Liu WJ, Shen Y, Ding J. Liu WJ, et al. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Feb;35(2):105-12. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003. PMID: 12545214 Review. Chinese. - C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton.
Martín-Encabo S, Santos E, Guerrero C. Martín-Encabo S, et al. Exp Cell Res. 2007 Nov 1;313(18):3881-91. doi: 10.1016/j.yexcr.2007.07.036. Epub 2007 Aug 14. Exp Cell Res. 2007. PMID: 17825818 - The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model system.
Boudreau RT, Hoskin DW. Boudreau RT, et al. Int Immunopharmacol. 2005 Sep;5(10):1507-18. doi: 10.1016/j.intimp.2005.05.007. Int Immunopharmacol. 2005. PMID: 16023602 Review.
Cited by
- BRG1 promotes progression of B-cell acute lymphoblastic leukemia by disrupting PPP2R1A transcription.
Kang Q, Ma D, Zhao P, Chai X, Huang Y, Gao R, Zhang T, Liu P, Deng B, Feng C, Zhang Y, Lu Y, Li Y, Fang Q, Wang J. Kang Q, et al. Cell Death Dis. 2024 Aug 26;15(8):621. doi: 10.1038/s41419-024-06996-w. Cell Death Dis. 2024. PMID: 39187513 Free PMC article. - Regulation of c-Myc Protein Abundance by a Protein Phosphatase 2A-Glycogen Synthase Kinase 3β-Negative Feedback Pathway.
Liu L, Eisenman RN. Liu L, et al. Genes Cancer. 2012 Jan;3(1):23-36. doi: 10.1177/1947601912448067. Genes Cancer. 2012. PMID: 22893788 Free PMC article. - MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
Cristóbal I, Rubio J, Santos A, Torrejón B, Caramés C, Imedio L, Mariblanca S, Luque M, Sanz-Alvarez M, Zazo S, Madoz-Gúrpide J, Rojo F, García-Foncillas J. Cristóbal I, et al. Cancers (Basel). 2020 Jun 22;12(6):1655. doi: 10.3390/cancers12061655. Cancers (Basel). 2020. PMID: 32580513 Free PMC article. - Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion.
Wei S, Chen X, McGraw K, Zhang L, Komrokji R, Clark J, Caceres G, Billingsley D, Sokol L, Lancet J, Fortenbery N, Zhou J, Eksioglu EA, Sallman D, Wang H, Epling-Burnette PK, Djeu J, Sekeres M, Maciejewski JP, List A. Wei S, et al. Oncogene. 2013 Feb 28;32(9):1110-20. doi: 10.1038/onc.2012.139. Epub 2012 Apr 23. Oncogene. 2013. PMID: 22525275 Free PMC article. - The evolution of small molecule enzyme activators.
Dow LF, Case AM, Paustian MP, Pinkerton BR, Simeon P, Trippier PC. Dow LF, et al. RSC Med Chem. 2023 Sep 22;14(11):2206-2230. doi: 10.1039/d3md00399j. eCollection 2023 Nov 15. RSC Med Chem. 2023. PMID: 37974956 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources